Uses of Probenecid
Probenecid is primarily used as a uricosuric agent for the treatment of hyperuricemia associated with gout and gouty arthritis, and as an adjuvant to enhance blood levels of certain antibiotics. 1
Primary Uses
1. Treatment of Gout
- Probenecid works by inhibiting renal tubular reabsorption of urate, increasing uric acid excretion in the urine
- It is recommended as an alternative first-line urate-lowering therapy (ULT) when xanthine oxidase inhibitors (XOIs) like allopurinol or febuxostat are:
- Contraindicated
- Not tolerated
- Ineffective 2
2. Antibiotic Adjuvant
- Used to elevate and prolong plasma levels of:
- Penicillins
- Ampicillin
- Methicillin
- Oxacillin
- Cloxacillin
- Nafcillin 1
- Functions by blocking the renal tubular secretion of these antibiotics, thereby increasing their blood concentration and duration of action 3
Clinical Considerations for Use in Gout
Patient Selection
- Best suited for patients who:
- Cannot tolerate XOIs (allopurinol or febuxostat)
- Have contraindications to XOIs
- Have normal to mildly impaired renal function 2
Important Limitations
- Not recommended as first-line ULT monotherapy in patients with:
Combination Therapy
- Can be effectively combined with XOIs (allopurinol or febuxostat) in patients with refractory gout 2, 5
- This combination approach is particularly useful when single-agent therapy fails to achieve target serum urate levels 2
Monitoring and Risk Management
Before Starting Probenecid
- Measure urinary uric acid levels 2
- Assess renal function (creatinine clearance) 2, 4
- Screen for history of kidney stones 2
During Treatment
- Monitor urinary uric acid levels 2
- Consider urine alkalinization (e.g., with potassium citrate) 2
- Recommend increased fluid intake to reduce risk of urolithiasis 2
- Monitor for drug interactions (probenecid affects many organic acid transporters) 3, 6
Efficacy and Response Rates
Research shows that probenecid can achieve target serum urate concentrations (<0.36 mmol/l) in approximately:
- 33% of patients when used as monotherapy
- 37% of patients when used in combination with allopurinol 5
Potential Side Effects and Concerns
- Urolithiasis (approximately 10% risk) 2
- Multiple drug interactions due to inhibition of organic anion transporters 3, 6
- Adverse events occur in approximately 13-19% of patients 5
- Requires more complex risk management compared to XOIs 2
Other Potential Effects
While not approved for these uses, probenecid has been studied for:
- Potential anti-hypertensive effects via inhibition of α-adrenergic receptors 7
- Significant alterations in metabolite levels that may affect various physiological processes 6
In summary, probenecid serves dual clinical roles as a uricosuric agent for gout management and as an adjuvant to enhance antibiotic efficacy, with specific considerations for patient selection and monitoring based on renal function and risk factors.